Back
Iovance Biotherapeutics, Inc. 10K Form
Sell
23
IOVA
Iovance Biotherapeutics, Inc.
Last Price:
$2.20
Seasonality Move:
8.53%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive IOVA News And Ratings
See the #1 stock for the next 7 days that we like better than IOVA
IOVA Financial Statistics
Sales & Book Value
| Annual Sales: | $164.1M |
|---|---|
| Cash Flow: | $-89.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.82 |
| Price / Book: | 1.24 |
Profitability
| EPS (TTM): | -1.20200 |
|---|---|
| Net Income (TTM): | $-397.6M |
| Gross Margin: | $17.7M |
| Return on Equity: | -54.43% |
| Return on Assets: | -42.48% |
Iovance Biotherapeutics, Inc. Earnings Forecast
Key Iovance Biotherapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 17 years for IOVA is 10.77%.
-
The Selling, General & Administrative Expenses for IOVA have been equal to 93.26% of Gross Profit Margin.
-
The Research & Development expenses have been 172.08% of Revenue.
-
The Net Earning history of IOVA is -226.84% of Total Revenues.
-
Per Share Earnings over the last 17 years have been positive in 8 years.
Iovance Biotherapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | IOVA |
| CUSIP: | 462260 |
| Website: | iovance.com |
Debt
| Debt-to-Equity Ratio: | 0.07 |
|---|---|
| Current Ratio: | 3.41 |
| Quick Ratio: | 2.92 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
IOVA Technical Analysis vs Fundamental Analysis
Sell
23
Iovance Biotherapeutics, Inc. (IOVA)
is a Sell
Is Iovance Biotherapeutics, Inc. a Buy or a Sell?
-
Iovance Biotherapeutics, Inc. stock is rated a SellThe current Iovance Biotherapeutics, Inc. [IOVA] share price is $2.20. The Score for IOVA is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.